Interleukin Genetics makes strategic divestment

By Chris Reidy, Globe Staff

Interleukin Genetics Inc., a Waltham company that develops and markets genetic tests, said it has executed an agreement to sell the Alan James Group assets of its subsidiary AJG Brands Inc. to Pep Products Inc., a subsidiary of Nutraceutical Corp., for $4.6 million in cash.

Interleukin Genetics chief executive Lewis H. Bender said in a statement: "While the Alan James Group business saw an increase in sales during the last fiscal year, and we were able to introduce two new products to the market in the past seven months, this transaction allows us to focus our efforts on growing our core genetic testing business."